News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,687 Results
Type
Article (42782)
Company Profile (290)
Press Release (696600)
Multimedia
Podcasts (106)
Webinars (22)
Section
Business (207102)
Career Advice (2037)
Deals (35929)
Drug Delivery (132)
Drug Development (82894)
Employer Resources (173)
FDA (16690)
Job Trends (15139)
News (350839)
Policy (33014)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2638)
Accelerated approval (50)
Adcomms (32)
Allergies (171)
Alliances (50391)
ALS (213)
Alzheimer's disease (1807)
Antibody-drug conjugate (ADC) (491)
Approvals (17087)
Artificial intelligence (695)
Autoimmune disease (302)
Automation (56)
Bankruptcy (363)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (225)
Biotechnology (193)
Bladder cancer (205)
Brain cancer (78)
Breast cancer (783)
Cancer (6093)
Cardiovascular disease (477)
Career advice (1732)
Career pathing (44)
CAR-T (344)
CDC (58)
Celiac Disease (3)
Cell therapy (929)
Cervical cancer (48)
Clinical research (72041)
Collaboration (2127)
Company closure (5)
Compensation (1421)
Complete response letters (82)
COVID-19 (2757)
CRISPR (110)
C-suite (1162)
Cystic fibrosis (153)
Data (8092)
Decentralized trials (3)
Denatured (32)
Depression (162)
Dermatology (89)
Diabetes (589)
Diagnostics (7023)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (334)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (286)
Earnings (92725)
Editorial (68)
Employer branding (21)
Employer resources (152)
Events (121726)
Executive appointments (1107)
FDA (20484)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1750)
Gene editing (238)
Generative AI (61)
Gene therapy (731)
GLP-1 (1067)
Government (4765)
Grass and pollen (6)
Guidances (408)
Healthcare (19262)
HIV (82)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (297)
Immuno-oncology (103)
Indications (196)
Infectious disease (3102)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (293)
Interviews (319)
IPO (16801)
IRA (51)
Job creations (3674)
Job search strategy (1435)
JPM (64)
Kidney cancer (21)
Labor market (102)
Layoffs (583)
Leadership (41)
Legal (7985)
Liver cancer (104)
Longevity (32)
Lung cancer (807)
Lymphoma (436)
Machine learning (60)
Management (59)
Manufacturing (1066)
MASH (191)
Medical device (13993)
Medtech (14121)
Mergers & acquisitions (20391)
Metabolic disorders (1518)
mRNA (223)
Multiple sclerosis (190)
NASH (17)
Neurodegenerative disease (424)
Neuropsychiatric disorders (105)
Neuroscience (3335)
Neurotech (1)
NextGen: Class of 2026 (6587)
Non-profit (4566)
Now hiring (78)
Obesity (713)
Opinion (296)
Ovarian cancer (231)
Pain (261)
Pancreatic cancer (320)
Parkinson's disease (368)
Partnered (33)
Patents (603)
Patient recruitment (685)
Peanut (62)
People (60374)
Pharmaceutical (61)
Pharmacy benefit managers (32)
Phase 1 (22522)
Phase 2 (31714)
Phase 3 (23618)
Pipeline (8979)
Policy (323)
Postmarket research (2600)
Preclinical (9572)
Press Release (64)
Prostate cancer (317)
Psychedelics (55)
Radiopharmaceuticals (341)
Rare diseases (1091)
Real estate (6034)
Recruiting (70)
Regulatory (25720)
Reports (56)
Research institute (2466)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (24)
RSV (88)
Schizophrenia (180)
Series A (294)
Series B (218)
Service/supplier (11)
Sickle cell disease (114)
Special edition (26)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3710)
State (2)
Stomach cancer (20)
Supply chain (127)
Tariffs (88)
The Weekly (71)
Vaccines (1112)
Venture capital (115)
Weight loss (459)
Women's health (128)
Worklife (20)
Date
Today (12)
Last 7 days (524)
Last 30 days (3308)
Last 365 days (30464)
2026 (13275)
2025 (30588)
2024 (35663)
2023 (40494)
2022 (51695)
2021 (56230)
2020 (54537)
2019 (47055)
2018 (35452)
2017 (32655)
2016 (32027)
2015 (38064)
2014 (31750)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27611)
Location
Africa (751)
Alabama (98)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (40509)
Australia (6643)
California (13480)
Canada (3811)
China (1398)
Colorado (571)
Connecticut (581)
Delaware (413)
Europe (88747)
Florida (2017)
Georgia (432)
Hawaii (3)
Idaho (63)
Illinois (1078)
India (93)
Indiana (606)
Iowa (23)
Japan (550)
Kansas (132)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1619)
Massachusetts (9715)
Michigan (366)
Minnesota (733)
Mississippi (6)
Missouri (146)
Montana (35)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3532)
New Mexico (29)
New York (3520)
North Carolina (1707)
North Dakota (9)
Northern California (6761)
Ohio (402)
Oklahoma (23)
Oregon (41)
Pennsylvania (2711)
Puerto Rico (29)
Rhode Island (50)
South America (1124)
South Carolina (86)
South Dakota (2)
Southern California (5320)
Tennessee (215)
Texas (2152)
United States (47615)
Utah (398)
Vermont (1)
Virginia (324)
Washington D.C. (80)
Washington State (1073)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
739,687 Results for "aktis oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aktis Oncology to Present at the BofA Securities Health Care Conference 2026
May 6, 2026
·
2 min read
Press Releases
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
May 12, 2026
·
11 min read
Press Releases
Aktis Oncology to Present at Upcoming March 2026 Investor Conferences
February 25, 2026
·
2 min read
Press Releases
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
April 16, 2026
·
6 min read
Press Releases
Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
April 22, 2026
·
5 min read
Press Releases
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
May 4, 2026
·
7 min read
IPO
UPDATE: Aktis To Become First Biotech IPO of 2026 With $318M Debut
Eli Lilly has expressed interest in participating in the IPO, with the regulatory filing revealing the obesity juggernaut’s plans to buy as much as $100 million worth of Aktis shares.
January 8, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 22, 2026
·
12 min read
Press Releases
Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results
March 30, 2026
·
9 min read
Press Releases
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
February 24, 2026
·
6 min read
1 of 73,969
Next
